Giansun Precision Technology Group
001400
Heilongjiang Tianyouwei Electronics
603202
Joy Kie Corporation
300994
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
CN Stock MarketDetailed Quotes
688136 Kexing Biopharm
- 38.52
- +0.72+1.90%
Market Closed Apr 24 15:00 CST
7.69BMarket Cap243.80P/E (TTM)
38.86High36.94Low60.54KlotVolume37.58Open37.80Pre Close228.69MTurnover3.03%Turnover Ratio243.80P/E (Static)199.64MShares42.1052wk High4.70P/B7.69BFloat Cap13.6752wk Low45.36Limit Up199.64MShs Float55.48Historical High30.24Limit Down5.08%Amplitude10.61Historical Low--Dividend TTM37.78Avg Price26.47KlotAsk--Div YieldTTM100Lot Size28.47KlotBid
Kexing Biopharm Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 11.75%1.41B | 7.15%1.04B | 17.09%759.89M | 11.79%360.66M | -4.32%1.26B | 2.65%969M | 3.11%648.96M | 19.62%322.64M | 2.39%1.32B | 5.33%944.01M |
| Operating revenue | 11.75%1.41B | 7.15%1.04B | 17.09%759.89M | 11.79%360.66M | -4.32%1.26B | 2.65%969M | 3.11%648.96M | 19.62%322.64M | 2.39%1.32B | 5.33%944.01M |
| Total operating cost | -12.22%1.34B | -8.98%975.68M | -6.63%700.34M | -0.18%343.2M | 5.21%1.53B | 3.72%1.07B | 17.55%750.09M | 41.66%343.82M | 16.60%1.46B | 24.37%1.03B |
| Operating cost | 19.79%440.53M | 13.37%312.95M | 19.15%217.47M | 11.81%98.68M | 13.45%367.75M | 18.27%276.05M | 23.93%182.52M | 43.69%88.26M | 22.50%324.16M | 29.60%233.42M |
| Operating tax surcharges | 5.08%12.23M | 8.77%8.9M | 21.30%6.36M | 31.29%3.19M | 20.10%11.64M | 17.48%8.18M | 21.61%5.24M | 23.48%2.43M | -0.94%9.69M | -2.99%6.97M |
| Operating expense | -13.42%596.77M | -16.51%448.02M | -12.82%334.86M | 1.07%177.45M | -16.73%689.29M | -9.98%536.59M | 7.91%384.1M | 42.15%175.57M | 9.55%827.73M | 18.13%596.09M |
| Administration expense | -0.98%85.96M | 2.24%61.22M | 4.43%42.22M | 0.31%19.72M | 1.11%86.82M | -13.41%59.88M | -14.02%40.43M | -15.15%19.66M | -5.10%85.87M | 13.30%69.16M |
| Financial expense | 31.01%40.85M | 36.03%31.15M | 41.65%19.11M | -3.70%8.95M | 108.95%31.18M | 449.86%22.9M | 222.99%13.49M | 220.16%9.29M | 196.88%14.92M | 73.66%4.16M |
| -Interest expense (Financial expense) | 11.34%43.57M | 8.78%32.55M | 8.47%21.24M | 3.02%10.04M | 48.76%39.13M | 89.38%29.92M | 138.51%19.58M | 207.97%9.74M | 227.77%26.31M | 182.52%15.8M |
| -Interest Income (Financial expense) | 45.41%-3.63M | 45.16%-3.09M | 44.40%-2.11M | 36.70%-1.12M | 9.15%-6.64M | -6.02%-5.63M | -12.81%-3.8M | -6.81%-1.77M | 19.27%-7.31M | 26.67%-5.31M |
| Research and development | -51.26%168.05M | -32.62%113.45M | -35.39%80.33M | -27.57%35.21M | 78.38%344.8M | 36.13%168.37M | 56.59%124.32M | 63.45%48.61M | 57.21%193.3M | 63.46%123.68M |
| Credit Impairment Loss | -154.96%-1.61M | -473.78%-3.76M | -600.76%-4.03M | -855.75%-3.16M | 280.53%2.93M | -5.70%1.01M | 31.32%804.61K | -78.63%418.67K | -191.53%-1.62M | -63.87%1.07M |
| Asset Impairment Loss | -43.23%-3.67M | -45.75%-3.04M | -173.98%-2.19M | -88.23%-1.1M | -414.66%-2.56M | -600.42%-2.09M | -471.10%-798.34K | -337.18%-586.1K | 26.32%-497.74K | 28.55%-298.24K |
| Other net revenue | ||||||||||
| Fair value change income | -12,331.77%-29.19M | -166.63%-13.94M | -166.63%-13.94M | ---- | 104.46%238.63K | 636.96%20.92M | 636.96%20.92M | ---- | -111.27%-5.35M | ---3.9M |
| Invest income | 42.86%9.33M | 32.79%5.82M | 73.89%4.08M | 123.44%1.79M | 199.87%6.53M | 74.89%4.39M | 98.37%2.35M | 91.25%799.6K | -76.32%2.18M | -67.50%2.51M |
| -Including: Investment income associates | -488.03%-90.95K | ---- | ---- | ---- | --23.44K | ---- | ---- | ---- | ---- | ---- |
| Asset deal income | -72.61%77.06K | 109.79%77.76K | --100.86K | --100.86K | -80.78%281.29K | -97.31%37.07K | ---- | ---- | 410.93%1.46M | -34.43%1.38M |
| Other revenue | 192.47%25.73M | 29.26%8M | -13.48%4.18M | -77.79%760.1K | 73.53%8.8M | 119.14%6.19M | 234.63%4.84M | 232.25%3.42M | 26.26%5.07M | 8.40%2.83M |
| Operating profit | 124.67%63.2M | 176.85%55.73M | 165.42%47.77M | 192.47%15.84M | -84.92%-256.23M | 15.57%-72.52M | -680.36%-73.01M | -156.29%-17.13M | -241.39%-138.56M | -207.10%-85.89M |
| Add:Non operating Income | -73.99%197.35K | 5,553.94%130.35K | 5,575.12%130.83K | 64,725.22%130.82K | 442.28%758.83K | -99.71%2.31K | -99.71%2.31K | --201.81 | -33.20%139.93K | 285.16%795.55K |
| Less:Non operating expense | 41.29%6.5M | 153.91%5.97M | 1,606.18%5.92M | -78.56%37.67K | 613.65%4.6M | 383.86%2.35M | 33.84%346.77K | 44.77%175.7K | -75.07%644.16K | -60.18%485.76K |
| Total profit | 121.88%56.9M | 166.64%49.89M | 157.23%41.98M | 192.07%15.94M | -87.01%-260.07M | 12.52%-74.86M | -731.73%-73.36M | -157.09%-17.31M | -245.42%-139.06M | -208.08%-85.58M |
| Less:Income tax cost | 146.23%29.85M | 315.94%36.14M | 238.77%32.52M | 159.71%4.45M | -39.67%-64.58M | 39.39%-16.74M | -107.08%-23.43M | -717.74%-7.45M | -5,425.54%-46.24M | -813.38%-27.61M |
| Net profit | 113.84%27.05M | 123.65%13.75M | 118.95%9.46M | 216.52%11.49M | -110.60%-195.49M | -0.28%-58.13M | -2,099.68%-49.92M | -133.87%-9.86M | -196.23%-92.82M | -176.97%-57.96M |
| Net profit from continuing operation | 113.84%27.05M | 123.65%13.75M | 118.95%9.46M | 216.52%11.49M | -110.60%-195.49M | -0.28%-58.13M | -2,099.68%-49.92M | -133.87%-9.86M | -196.23%-92.82M | -176.97%-57.96M |
| Less:Minority Profit | 14.70%-4.43M | 10.08%-3.43M | -2.32%-2.42M | 16.30%-915.19K | -105.50%-5.2M | -206.22%-3.81M | -488.72%-2.36M | ---1.09M | ---2.53M | ---1.25M |
| Net profit of parent company owners | 116.54%31.48M | 131.63%17.18M | 124.97%11.88M | 241.49%12.4M | -110.74%-190.29M | 4.24%-54.31M | -1,741.43%-47.56M | -130.11%-8.77M | -193.61%-90.3M | -175.31%-56.72M |
| Earning per share | ||||||||||
| Basic earning per share | 116.67%0.16 | 133.33%0.09 | 125.00%0.06 | 250.00%0.06 | -113.33%-0.96 | 6.90%-0.27 | -2,500.00%-0.24 | -110.53%-0.04 | -191.84%-0.45 | -176.32%-0.29 |
| Diluted earning per share | 116.67%0.16 | 133.33%0.09 | 125.00%0.06 | 250.00%0.06 | -113.33%-0.96 | 6.90%-0.27 | -2,500.00%-0.24 | -110.53%-0.04 | -191.84%-0.45 | -176.32%-0.29 |
| Other composite income | 17,987.10%1.12M | 357.53K | 345.38K | 386.8K | -6.26K | |||||
| Other composite income of parent company owners | 17,987.10%1.12M | --357.53K | --345.38K | --386.8K | ---6.26K | ---- | ---- | ---- | ---- | ---- |
| Total composite income | 114.41%28.17M | 124.27%14.11M | 119.64%9.81M | 220.44%11.88M | -110.61%-195.49M | -0.28%-58.13M | -2,099.68%-49.92M | -133.87%-9.86M | -196.23%-92.82M | -176.97%-57.96M |
| Total composite income of parent company owners | 117.13%32.6M | 132.29%17.54M | 125.70%12.22M | 245.91%12.79M | -110.75%-190.3M | 4.24%-54.31M | -1,741.43%-47.56M | -130.11%-8.77M | -193.61%-90.3M | -175.31%-56.72M |
| Total composite income of minority owners | 14.70%-4.43M | 10.08%-3.43M | -2.32%-2.42M | 16.30%-915.19K | -105.50%-5.2M | -206.22%-3.81M | -488.72%-2.36M | ---1.09M | ---2.53M | ---1.25M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | -- | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.